Avoidance of Oxidative Stressors (e.g., Fava Beans, Sulfa Drugs, Antimalarials)

Treatment for G6pd Deficiency

Typical Dosage: Strict adherence to known trigger avoidance lists

Effectiveness
95%
Safety Score
100%
Clinical Trials
0
Participants
0

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
100
DangerousModerateSafe
Treatment Details
Dosage Range
Strict adherence to known trigger avoidance lists
Time to Effect
Immediate (upon avoidance)
Treatment Duration
Lifetime
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,500
Side Effect Mgmt:$0
Total Annual:$1,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
0
QALYs Gained
0.8
Comparison vs No preventative action
Cost Difference
$0/year
Same cost
QALY Difference
+0.80 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Avoidance of Oxidative Stressors (e.g., Fava Beans, Sulfa Drugs, Antimalarials) Outcomes

for G6pd Deficiency

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+100%
Remission Rate
+100%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov